Fisher & Paykel Healthcare Corporation Limited
FSPKF · OTC
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $12,289,034 | $17,451,284 | $23,869,050 | $15,310,167 |
| - Cash | $173,790 | $264,500 | $116,600 | $82,000 |
| + Debt | $85,852 | $153,300 | $150,900 | $189,100 |
| Enterprise Value | $12,201,096 | $17,340,084 | $23,903,350 | $15,417,267 |
| Revenue | $637,578 | $1,280,300 | $951,200 | $939,100 |
| % Growth | -50.2% | 34.6% | 1.3% | – |
| Gross Profit | $404,236 | $530,200 | $588,700 | $558,300 |
| % Margin | 63.4% | 41.4% | 61.9% | 59.5% |
| EBITDA | $210,981 | $654,300 | $275,700 | $246,400 |
| % Margin | 33.1% | 51.1% | 29% | 26.2% |
| Net Income | $123,391 | $377,200 | $153,200 | $25,300 |
| % Margin | 19.4% | 29.5% | 16.1% | 2.7% |
| EPS Diluted | 0.21 | 0.64 | 0.26 | 0.043 |
| % Growth | -67.2% | 146.2% | 510.3% | – |
| Operating Cash Flow | $142,392 | $548,600 | $233,000 | $273,100 |
| Capital Expenditures | -$30,124 | -$103,000 | -$39,600 | -$52,900 |
| Free Cash Flow | $112,268 | $445,600 | $193,400 | $220,200 |